BI Asset Management Fondsmaeglerselskab A S Increases Stock Position in Intuitive Surgical, Inc. $ISRG

BI Asset Management Fondsmaeglerselskab A S increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 62,795 shares of the medical equipment provider’s stock after buying an additional 5,992 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Intuitive Surgical were worth $28,948,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Holos Integrated Wealth LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. boosted its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $28,000. Caitlin John LLC purchased a new position in shares of Intuitive Surgical in the third quarter valued at $30,000. Finally, Laurel Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $406.78 on Friday. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88. The company has a market capitalization of $144.07 billion, a PE ratio of 49.31, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46. The business’s fifty day moving average is $438.43 and its 200 day moving average is $490.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock valued at $3,059,135 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Truist Financial reduced their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a report on Wednesday, April 15th. Raymond James Financial decreased their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Finally, HSBC lowered their price target on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $573.42.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.